https://www.selleckchem.com/pr....oducts/chir-99021-ct
The aim of this study was to assess the effect of continuing immune suppressive therapy in solid organ transplant recipients (SOTR) with coronavirus disease 2019 (COVID-19). Systematic review and meta-analysis of data on 202 SOTR with COVID-19, published as case reports or case series. We extracted clinical, hemato-chemical, imaging, treatment, and outcome data. Most patients were kidney recipients (61.9%), males (68.8%), with median age of 57years. The majority was on tacrolimus (73.5%) and mycophenolate (65.8%). Mortali
Like
Comment
Share
